Skip to main content

Drug Interactions between Daptacel (DTaP) and rsv vaccine, pref a-pref b, recombinant

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

pertussis, acellular RSV vaccine, preF A-preF B, recombinant

Applies to: Daptacel (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular) and rsv vaccine, pref a-pref b, recombinant

Consumer information for this interaction is not currently available.

MONITOR: Coadministration with the bivalent respiratory syncytial virus (RSV) vaccine may decrease the immune response to the pertussis component of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed (Tdap). When these vaccines were coadministered in healthy non-pregnant women, lower geometric mean antibody concentrations (GMCs) to the pertussis antigens were measured compared to separate administration and did not meet non-inferiority criteria. Immune responses to the RSV and remaining Tdap antigens were non-inferior to those after separate administration. No safety concerns were identified, and the clinical relevance is unknown.

MANAGEMENT: Patients should be monitored closely for immune responses after receiving bivalent RSV and Tdap vaccines concurrently.

References

  1. "Product Information. Abrysvo (RSV vaccine, preF A-preF B, recombinant)." Pfizer U.S. Pharmaceuticals Group
  2. "Product Information. Abrysvo (RSV vaccine, preF A-preF B, recombinant)." Pfizer Ltd (2023):

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer